Sirolimus BSA Conjugate from Molecular Depot

SAN DIEGO - March 1, 2020 - PRLog -- Molecular Depot introduces the first commercially available Sirolimus BSA Conjugate.
The product consists of a concentrated solution of Bovine Serum Albumin (BSA) conjugated to Sirolimus. A carbon spacer arm of 19.0 Å links BSA to the Sirolimus moiety. Each BSA molecule contains several Sirolimus units. Dilutions of the provided conjugate can be made in 1X Phosphate Buffer Saline, pH 7.4.

Product
Catalog number:  P2010025
Purity:  > 95%
Concentration:  1 mg/mL
Package Size:  0.5 mg
Molecular Weight:  71 kDa (average)
Storage:  -20°C. Avoid repeated freeze/thaw cycles.
Other names:  BSA-Sirolimus, Sirolimus-BSA, BSA conjugated to Sirolimus, Sirolimus Bovine Serum Albumin Conjugate, Sirolimus [BSA], BSA- Rapamycin, Rapamycin -BSA, BSA conjugated to Rapamycin, Rapamycin Bovine Serum Albumin Conjugate, Rapamycin [BSA]
Keywords:  BSA conjugate, Sirolimus, (-)-Rapamycin; Rapamycin; Sirolimús; Sirolimusum
Buffer:  1X Phosphate Buffer Saline, pH 7.4.


About Sirolimus

Also known as Rapamycin, Sirolimus is a cyclic macrolide naturally produced by a strain of Streptomyces hygroscopicus. The name Rapamycin derives from the name of the island where the fungus was first isolated: Rapa Nui, also known as Easter Island. Sirolimus originally exhibited antifungal activities and later found to have immunosuppressive and antitumor activities. Sirolimus inhibits the production of cyotkines by blocking the transcriptional activation of cytokine genes.

More Information
For more information about this product, please visit:
https://moleculardepot.com/product/sirolimus-bsa-conjugate/